✦ LIBER ✦

Use of L-asparaginase and cytosine arabinoside for refractory acute lymphocytic leukemia with particular reference to T-cell leukemia

✍ Scribed by Steuber, C. Philip ;Levy, Gary J. ;Nix, William L. ;Shepherd, Dell A. ;Starling, Kenneth A. ;Fernbach, Donald J.

Publisher: John Wiley and Sons
Year: 1978
Tongue: English
Weight: 353 KB
Volume: 5
Category: Article
ISSN: 0098-1532
DOI: 10.1002/mpo.2950050105

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Ten patients with late‐stage acute lymphocytic leukemia were treated with L‐asparaginase and cytosine arabinoside. Complete remission was achieved in 8 patients including 5 of 5 patients with T‐cell leukemia. Major toxicity included anaphylactic reactions in 3 of the 10 patients.

📜 SIMILAR VOLUMES

L-asparaginase used with cytosine arabin

L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone

✍ Smithson, William A. ;Gilchrist, Gerald S. ;Burgert, E. Omer 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB

## Abstract Eleven patients with acute lymphocytic leukemia in relapse were treated with L‐asparaginase and cytosine arabinoside (1‐β‐D‐arabinofuranosylcytosine) in induction therapy and the same drugs plus cyclophosphamide in maintenance therapy. Three patients had complete remissions lasting 6, 1

Mitoxantrone and high-dose cytosine arab

Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia

✍ Hagop M. Kantarjian; Ronald L. Walters; Michael J. Keating; Elihu H. Estey; SUSA 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB 👁 2 views

Twenty-five adult patients with refractory acute lymphocytic leukemia received salvage therapy with mitoxantrone 5 mg/m2 intravenously over 1 hour daily for 5 days and cytosine arabinoside 3 g/m2 intravenously over 2 hours every 12 hours for six doses. Overall, nine patients (36%) achieved complete